Payers are evaluating provider and reimbursement policies, seeking value in precision health. This is shifting paradigms in precision health innovation, favoring models with strategic and agile approaches to discovery research, translation and implementation. These models emphasize partnerships and commitments around evidence thresholds upstream of data collection, and they are demonstrating the potential and promise of precision health for transforming clinical care.

During this session, Vital Innovation and Alva10 will present new and emerging pathways for generating this real world evidence, while Optum will highlight the payer perspective and role for researcher, industry and payer collaborations.

Ability Level: Intermediate

Session ID: 502967